Genetic Testing, Insurance Economics, and Societal Responsibility
DOI10.1080/10920277.1999.10595764zbMATH Open1082.62529OpenAlexW2054897894MaRDI QIDQ5718331FDOQ5718331
Authors: Patrick L. Brockett, Maureen Carter, Richard D. MacMinn
Publication date: 13 January 2006
Published in: North American Actuarial Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10920277.1999.10595764
Recommendations
Applications of statistics to biology and medical sciences; meta analysis (62P10) Applications of statistics to actuarial sciences and financial mathematics (62P05)
Cited In (12)
- Genetics, Alzheimer’s Disease, and Long-Term Care Insurance
- Effective Underwriting in the Genetic Testing Era
- Ethical Issues Resulting from Genetic Technology
- Federal Regulation of Use of Genetic Information by Insurers
- Restricting Insurers’ Use of Genetic Information
- Social Implications of Genetic Testing
- The Future of Risk Classification in the Age of Predictive DNA-Based Testing
- The Current State of Genetic Testing
- What Does Genetic Technology Have to Do with Ethics?
- A simulation study for multifactorial genetic disorders to quantify the impact of polygenic risk scores on critical illness insurance
- Genetics and Insurance: What have we Learned So Far?
- Optimal risk classification with an application to substandard annuities
This page was built for publication: Genetic Testing, Insurance Economics, and Societal Responsibility
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5718331)